A comparison between different postoperative treatment modalities of uterine carcinosarcoma
- 30 April 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (1) , 166-170
- https://doi.org/10.1016/j.ygyno.2004.12.006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999Gynecologic Oncology, 2004
- Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinomaInternational Journal of Gynecologic Cancer, 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of the literatureInternational Journal of Gynecologic Cancer, 2002
- Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk populationEuropean Journal of Surgical Oncology, 2001
- Malignant Mixed Müllerian Tumor of the Uterus. Features Favoring its Origin from a Common Cell Clone and an Epithelial-to-Mesenchymal Transformation Mechanism of HistogenesisTumori Journal, 1998
- Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF StudyGynecologic Oncology, 1997
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990
- Adjuvant therapy for Stage I uterine sarcomaAmerican Journal of Obstetrics and Gynecology, 1987